Li-Li Zhao Selected Research

CAP protocol 2

11/2019

Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Li Zhao Research Topics

Disease

8	Neoplasms (Cancer) 06/2022 - 03/2012
6	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 01/2014
6	Infections 03/2017 - 02/2009
5	Inflammation (Inflammations) 01/2022 - 08/2017
5	Tuberculosis (Tuberculoses) 04/2020 - 12/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2004
3	Stomach Neoplasms (Stomach Cancer) 06/2022 - 03/2012
3	Myocardial Infarction 01/2022 - 08/2014
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Ischemia 01/2022 - 01/2020
2	Necrosis 01/2021 - 08/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2018
2	Hyperplasia 08/2017 - 01/2017
2	Insulin Resistance 01/2017 - 12/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 05/2014
1	Hypersensitivity (Allergy) 07/2022
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2022
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Gout 02/2021
1	Hyperuricemia 02/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Acute Lung Injury 10/2020
1	Lymphatic Metastasis 08/2020
1	Vascular Remodeling 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Chest Pain (Chest Pains) 10/2019
1	Liver Diseases (Liver Disease) 10/2019
1	Coronary Disease (Coronary Heart Disease) 10/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019
1	Bradycardia 05/2019
1	Cardiac Sinus Arrest 05/2019
1	Carcinogenesis 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Atherosclerosis 12/2017
1	Stroke (Strokes) 12/2017
1	Ischemic Stroke 12/2017
1	Hemorrhage 09/2017
1	Postoperative Hemorrhage 09/2017
1	Spondylolisthesis 09/2017
1	Communicable Diseases (Infectious Diseases) 03/2017

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 10/2020 - 12/2013
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 08/2018
2	Sirtuin 1IBA 01/2020 - 08/2017
2	Biological ProductsIBA 01/2020 - 01/2020
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2020 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	CytokinesIBA 08/2017 - 12/2010
2	Insulin (Novolin)FDA Link 01/2017 - 12/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2015
2	MicroRNAs (MicroRNA)IBA 08/2014 - 05/2014
1	Acetic Acid (Vinegar)FDA LinkGeneric 07/2022
1	Serotonin (5 Hydroxytryptamine)IBA 07/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	6-methyladenineIBA 06/2022
1	N-methyladenosineIBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	MethyltransferasesIBA 06/2022
1	liriodendrinIBA 01/2022
1	Uric Acid (Urate)IBA 02/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Polysaccharides (Glycans)IBA 10/2020
1	LipopolysaccharidesIBA 10/2020
1	Toll-Like Receptor 4IBA 10/2020
1	cycloastragenolIBA 01/2020
1	Contractile ProteinsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Clofazimine (Lamprene)FDA Link 11/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019
1	LipidsIBA 10/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2019
1	Nonprescription Drugs (Patent Medicines)IBA 05/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2019
1	Dobutamine FDA LinkGeneric 05/2019
1	Atropine FDA LinkGeneric 05/2019
1	Dopamine (Intropin)FDA LinkGeneric 05/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Angiotensin IIIBA 01/2019
1	arctigeninIBA 01/2018
1	ApolipoproteinsIBA 12/2017
1	Apolipoproteins E (ApoE)IBA 12/2017
1	danaparoid (Orgaran)FDA Link 12/2017
1	NF-kappa B (NF-kB)IBA 08/2017
1	butyl phosphorotrithioate (DEF)IBA 03/2017
1	Anti-Infective Agents (Microbicides)IBA 03/2017
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017

Therapy/Procedure

4	Therapeutics 10/2019 - 10/2012
2	Ligation 08/2017 - 01/2017
1	Moxibustion 07/2022
1	Gastrectomy 08/2020
1	CAP protocol 2 11/2019
1	Aftercare (After-Treatment) 10/2019
1	Operative Time 09/2017
1	Decompression 09/2017